The Effect of Foot Bath with Magnesium Sulfate on Blood Pressure Stability in Hypertensive Patients

Rachmat Susanto; Arif Hendra Kusuma; Fa’iq Hanif Mubarok

doi:10.58905/jse.v6i1.649

Authors

Rachmat Susanto Stikes Serulingmas Cilacap, Cilacap, Indonesia
Arif Hendra Kusuma Stikes Serulingmas Cilacap, Cilacap, Indonesia
Fa’iq Hanif Mubarok Stikes Serulingmas Cilacap, Cilacap, Indonesia

DOI:

https://doi.org/10.58905/jse.v6i1.649

Keywords:

ARV, Blood Pressure Variability, Foot Bath, Hypertension, Magnesium Sulfate, RMSSD

Abstract

Fluctuations in blood pressure (BPV) can increase the risk of heart related problems. Simple, non-medical treatments, like foot baths with ma nenesium sulfate (MgSO₄), may help lower blood pressure and promote overall heart health. To analyze the effect of foot baths with MgSO₄ on the mean andshort-term variability of systolic blood pressure (SBP) and diastolic blood pressure (DBP) in hypertensive patients. A randomized controlled trial was conducted at the Maos Community Health Center (July–August 2025) with 60 hypertensive patients randomly assigned to intervention (foot immersion with 2% MgSO₄) or control (plain water). Blood pressure and variability (RMSSD, ARV, CV%) were measured across 15 sessions and analyzed using Repeated Measures ANCOVA (p < 0.05). The mean SBP was significantly lower in the intervention group (140.1 vs 155.4 mmHg; p<0.001; d=1.26). RMSSD (9.6 vs 12.7; p<0.001) and ARV (7.4 vs 10.7; p<0.001) were significantly lower in the intervention group, indicating better SBP stability. ANCOVA revealed a significant group effect on RMSSD (F=11.31; p=0.0014; η²=0.17) and ARV (F=17.50; p=0.0001; η²=0.24). DBP did not show significant differences.Foot baths with MgSO₄ reduced the average SBP and improved short-term SBP stability. This intervention has potential as a complementary non-pharmacological therapy for hypertension.

Downloads

Download data is not yet available.

References

G. Parati, J. E. Ochoa, C. Lombardi, and G. Bilo, “Assessment and management of blood pressure variability,” Nat. Rev. Cardiol., vol. 17, pp. 389–403, 2020, doi: 10.1038/s41569-019-0310-1.

at al Xu, “Short-term blood pressure variability and cardiovascular outcomes,” Hypertension, vol. 75, no. 4, pp. 1092–1099, 2020, doi: 10.1161/HYPERTENSIONAHA.119.14587.

L. & et al Mena, “Blood pressure variability and cardiovascular risk: Clinical implications,” Curr. Hypertens. Rep., vol. 23, no. 4, p. 20, 2021.

Chen & et al, “Magnesium supplementation and blood pressure: A systematic review and meta-analysis,” Nutrients, vol. 14, no. 5, p. 1052, 2022, doi: 10.3390/nu14051052.

Suksomboon & et al, “Efficacy of magnesium salts in hypertension management,” J. Clin. Hypertens., vol. 25, no. 1, pp. 56–65, 2023, doi: 10.1111/jch.14646.

L. Kass, J. Weekes, and L. Carpenter, “Effect of magnesium supplementation on blood pressure: A meta-analysis,” Eur. J. Clin. Nutr., vol. 71, no. 5, pp. 573–580, 2017, doi: 10.1038/ejcn.2017.31.

R. H. Waring, “Magnesium absorption through the skin,” Magnes. Res., vol. 26, no. 1, pp. 45–52, 2013, doi: 10.1684/mrh.2013.0335.

S. Acharya and M. Singh, “Efficacy of non-pharmacological interventions in hypertension management,” J. Hypertens. Res., vol. 25, no. 4, pp. 342–348, 2020, doi: 10.1016/j.jhr.2020.05.001.

T. Nugraheni and et al., “Effect of foot bath therapy with salt on blood pressure in hypertensive patients,” Pena Med. J. Kesehat., vol. 13, no. 2, pp. 87–94, 2023, doi: https://doi.org/10.31983/penamedika.v13i2.10021.

G. Parati, J. E. Ochoa, C. Lombardi, and G. Bilo, “Assessment and management of blood pressure variability,” Nat. Rev. Cardiol., vol. 10, no. 3, pp. 143–155, 2013, doi: 10.1038/nrcardio.2013.1.

G. Parati, J. E. Ochoa, and C. Lombardi, “Blood pressure variability and cardiovascular risk,” Hypertension, vol. 75, no. 3, pp. 691–697, 2020, doi: 10.1161/HYPERTENSIONAHA.119.14032.

J. Chen and et al., “Magnesium supplementation and blood pressure: A systematic review and meta-analysis,” Nutrients, vol. 14, no. 5, p. 1052, 2022, doi: https://doi.org/10.3390/nu14051052.

Z. Zhang and et al., “Effect of magnesium salts on blood pressure regulation in hypertensive patients: A comprehensive review,” J. Clin. Nutr. Ther., vol. 30, no. 4, pp. 182–191, 2022, doi: 10.1016/j.jnut.2022.04.002.

A. M. Romani, “Beneficial role of Mg2+ in prevention and treatment of hypertension,” Front. Biosci., vol. 18, pp. 607–631, 2013, doi: https://doi.org/10.2741/4120.

D. Ettehad and et al., “Blood pressure lowering for prevention of cardiovascular disease and death,” Lancet, vol. 387, no. 10022, pp. 957–967, 2016, doi: https://doi.org/10.1161/S0140-6736(15)01225-8.

A. M. Romani and et al., “Magnesium and its cardiovascular impact in hypertension patients,” J. Cardiovasc. Pharmacol., vol. 75, no. 5, pp. 456–467, 2020, doi: 10.1097/FJC.0000000000000560.

C. Cuspidi, M. Tadic, C. Sala, and G. Grassi, “Blood pressure variability and target organ damage in hypertension,” High Blood Press. & Cardiovasc. Prev., vol. 26, no. 1, pp. 9–17, 2019, doi: 10.1007/s40292-019-00311-5.

L. Mena, S. Pintos, N. V Queipo, J. A. Aizpúrua, G. Maestre, and T. Sulbaran, “A reliable index for the prognostic significance of blood pressure variability,” J. Hypertens., vol. 23, no. 3, pp. 505–511, 2005, doi: 10.1097/01.hjh.0000160205.81652.5a.

M. M. Koh and W. J. Lee, “Role of blood pressure variability in the development of organ damage: Implications for clinical practice,” J. Hypertens. Ther., vol. 9, no. 1, pp. 19–27, 2021, doi: 10.1016/j.jht.2021.02.004.

R. D. Toh and W. L. Ooi, “Transdermal magnesium supplementation in hypertension treatment: A meta-analysis,” Nutr. Rev., vol. 80, no. 6, pp. 1413–1425, 2022, doi: 10.1093/nutrit/nuz123.

S. E. Fisher and et al., “Blood pressure variability and its impact on hypertension treatment: A cross-sectional study,” Hypertens. Res., vol. 45, no. 7, pp. 1098–1107, 2022, doi: 10.1038/s41571-022-00685-1.